OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

siTran 2.0 siRNA transfection reagent (1 ml)

Be the first to review this product
SKU
TT320002
siTran 2.0 siRNA transfection reagent (1ml)
More Transfection Reagents
  • TT320002 is the updated version of TT300002.
Size:
1 ml 500 ul 5 x 1 ml
  $430.00
In Stock*
Specifications
Specifications
Product Data
Components One (1) Vial of siTran 2.0 Transfection Reagent (1 mL)
One (1) Vial of 5x transfection buffer, 8 mL
Features » Exceptional siRNA transfection efficiency
» Great for siRNA/DNA co-transfection
» Broad cell spectrum
» Low cell cytotoxicity
Quality Control Each batch of siTran 2.0 Transfection Reagent has been tested using a standard transfection protocol.
Stability The transfection reagent is stable for one (1) year from date of shipping when stored properly.
Storage Upon receipt, please store the siTran 2.0 Transfection Reagent at 4°C. The transfection buffer can be stored at room temperature.
Type Transfection
OTI Replacement Note TT320002 is the updated version of TT300002.
Shipping Ambient
Description siTran 2.0 siRNA transfection reagent (1ml)
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents

file-alt Citations

Irx3 ameliorates post myocardial infarction cardiac dysfunction by regulating both inflammatory and fibrotic pathways
Fu, Peng, Zhang et al
Communications Biology (2026)
AI Summary: OriGene’s siTran 2.0 reagent (TT320002) was used for siRNA transfection in experiments investigating the role of Irx3 in cardiac cells, enabling targeted gene knockdown to study its effects on post-myocardial infarction repair.
Snippet: (stable Irx3 overexpression transfected with Ppm1l-specific siRNA and exposed to 24 h OGD). siRNA transfection was performed using siTran 2.0 reagent (OriGene, TT320002, Wuxi, China) according to the manufacturer’s instructions
SUCLG2 contributes to platinum resistance in lung adenocarcinoma through enhancing succinylation of GAC and glutamine metabolism
Wang, Wang, Wang et al
Research Square (2026)
AI Summary: OriGene products contributed to this study by providing SUCLG2 siRNA (SR305801) for gene silencing experiments and the siTran 2.0 siRNA Transfection Reagent (TT320002) for efficient siRNA delivery in lung adenocarcinoma cells.
Snippet: … REAGENTS The SUCLG2 siRNA (SR305801) was ordered from Origene. … PLASMIDS PCR-amplified SUCLG2 was cloned into the pcDNA-His/v5. CELL CULTURE AND TRANSFECTION: Cell culture: The human lung epithel;- For siRNA transfection, cells at 50% confluence were transfected using the siTran 2.0 siRNA Transfection Reagent (OriGene, TT320002), following the manufacturers’
Lactylation-based machine algorithm combined with multi-omics analysis to predict prognosis in cervical cancer
Wang, Ning, Li et al
Oncol Lett (2026) 31 (4), 133 DOI: 10.3892/ol.2026.15486
AI Summary: OriGene's siTran 2.0™ transfection reagent (cat. no. TT320002) was used to deliver HMGN1-specific and control siRNAs into SiHa and HeLa cervical cancer cells, enabling functional studies of HMGN1's role in cell proliferation and cell cycle regulation.
Snippet: SiHa and HeLa cells were seeded into 6-well plates and transfected with HMGN1-specific small interfering RNA (siRNA) or non-targeting control (NC) siRNA using siTran 2.0 (cat. no. TT320002;Origene Technologies, Inc.)
FigureFigureFigure
Acetylation-dependent nuclear translocation of EXOC4 regulates KU70 methylation to facilitate non-homologous end joining
Li, Sun, Yang et al
Cell Death Differ (2026)
AI Summary: OriGene’s siTran 2.0 siRNA transfection reagent (TT320002) and EXOC4-siRNAs were used for gene knockdown experiments to investigate the role of EXOC4 in chemoradiotherapy resistance in gastric cancer.
Snippet: For knockdown experiments, cells were transiently transfected with siTran 2.0 siRNA transfection reagent from OriGene (TT320002). EXOC4-siRNAs were from
Modulation of Ferroptosis by the Irx3-Etfa Pathway Protects Against Cardiac Hypertrophy
Li, Zhang, Fu et al
FASEB J (2026) 40 (3), e71524 DOI: 10.1096/fj.202502033RR
AI Summary: OriGene’s siTran 2.0 reagent (Cat. No. TT320002) was used for siRNA transfection in experiments investigating the regulatory effects of Irx3 and Etfa on cardiac hypertrophy and ferroptosis.
Snippet: CAGAAGCAGUUCAAUUACA-3′) and for Irx3 (5′-GAUCGAUUUGGAGAACUUAGA-3′) was selected for subsequent experiments. siRNA transfection was performed using the siTran 2.0 reagent (Cat. No. TT320002, OriGene, Wuxi, China),
HHIPL2 positively governs Hedgehog signaling to accelerate non-small cell lung cancer progression via enhancing HNRNPC-mediated HNF1A mRNA stabilization
Mu, Liu, Song et al
Cell Death Dis (2025) 17 (1), 103 DOI: 10.1038/s41419-025-08331-3
Cited by 1
AI Summary: In this study, OriGene's siTran2.0TM siRNA transfection reagent (TT320002) was used to introduce RNA interference molecules into cells, enabling the investigation of gene function in the regulation of Hedgehog signaling and non-small cell lung cancer progression.
Snippet: RNA using LipoMaxTM reagent (32012, Sudgen Biotechnology) or siTran2.0TM siRNA transfection reagent (TT320002, Origene) in serum-free Opti-MEM (Gibco) according to the instruction manual
FigureFigureFigure
Showing 1-6 of 26 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products